The NKG2A immune checkpoint - a new direction in cancer immunotherapy

被引：91

作者：

Creelan, Benjamin C. ^{[1
]}

Antonia, Scott J. ^{[1
,2
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol Dept, Tampa, FL 33612 USA

[2] Duke Canc Inst, DCI Ctr Canc Immunol, Durham, NC USA

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2019年 / 16卷 / 05期

关键词：

D O I：

10.1038/s41571-019-0182-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Inhibition of the NKG2A immune checkpoint restores natural killer cell and T cell effector function in preclinical cancer models. In addition, NKG2A blockade in combination with other therapeutic antibodies is showing encouraging responses in a subset of patients with metastatic colorectal or head and neck cancer. However, established biomarkers of response are lacking, and larger trials are needed to enable firm conclusions to be drawn about whether NKG2A inhibition complements existing immunotherapies.

引用

页码：277 / 278

页数：2

共 9 条

[1] Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells [J].

Andre, Pascale ;

Denis, Caroline ;

Soulas, Caroline ;

Bourbon-Caillet, Clarisse ;

Lopez, Julie ;

Arnoux, Thomas ;

Blery, Mathieu ;

Bonnafous, Cecile ;

Gauthier, Laurent ;

Morel, Ariane ;

Rossi, Benjamin ;

Remark, Romain ;

Breso, Violette ;

Bonnet, Elodie ;

Habif, Guillaume ;

Guia, Sophie ;

Lalanne, Ana Ines ;

Hoffmann, Caroline ;

Lantz, Olivier ;

Fayette, Jerome ;

Boyer-Chammard, Agnes ;

Zerbib, Robert ;

Dodion, Pierre ;

Ghadially, Hormas ;

Jure-Kunkel, Maria ;

Morel, Yannis ;

Herbst, Ronald ;

Narni-Mancinelli, Emilie ;

Cohen, Roger B. ;

Vivier, Eric .

CELL, 2018, 175 (07) :1731-+

[2] HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression [J].

Bossard, Celine ;

Bezieau, Stephane ;

Matysiak-Budnik, Tamara ;

Volteau, Christelle ;

Laboisse, Christian L. ;

Jotereau, Francine ;

Mosnier, Jean-Francois .

INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) :855-863

[3]

Cohen R., 2018, J IMMUNOTHER CANC S2, V6, P434

[4]

Diamond JR, 2018, ANN ONCOL, V29

[5] CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence [J].

Petrie, Emma J. ;

Clements, Craig S. ;

Lin, Jie ;

Sullivan, Lucy C. ;

Johnson, Darryl ;

Huyton, Trevor ;

Heroux, Annie ;

Hoare, Hilary L. ;

Beddoe, Travis ;

Reid, Hugh H. ;

Wilce, Matthew C. J. ;

Brooks, Andrew G. ;

Rossjohn, Jamie .

JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (03) :725-735

[6]

SEGAL NH, 2018, J CLIN ONCOL S, V36

[7] Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma [J].

Sheu, BC ;

Chiou, SH ;

Lin, HH ;

Chow, SN ;

Huang, SC ;

Ho, HN ;

Hsu, SN .

CANCER RESEARCH, 2005, 65 (07) :2921-2929

[8]

Tinker A., 2016, EJC SUPPL, V69, P97

[9] NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines [J].

van Montfoort, Nadine ;

Borst, Linda ;

Korrer, Michael J. ;

Sluijter, Marjolein ;

Marijt, Koen A. ;

Santegoets, Saskia J. ;

van Ham, Vanessa J. ;

Ehsan, Ilina ;

Charoentong, Pornpimol ;

Andre, Pascale ;

Wagtmann, Nicolai ;

Welters, Marij J. P. ;

Kim, Young J. ;

Piersma, Sytse J. ;

van der Burg, Sjoerd H. ;

van Hall, Thorbald .

CELL, 2018, 175 (07) :1744-+

← 1 →